HPV Test Approval Standards Laid Out In FDA Draft Guidance
This article was originally published in Clinica
Executive Summary
FDA issued draft guidance on clinical study designs to support PMAs for diagnostics that detect, or detect and differentiate, human papillomaviruses linked to cervical cancer.
You may also be interested in...
Big Week For HPV Dx: FDA Finalizes Guidance, Task Force Supports Solo Testing
An important task force drafted new recommendations supporting human papillomavirus tests as a solo first-line screen for cervical cancer in some women, followed up by a US FDA final guidance document detailing for test-makers how to best ensure assays for the cervical cancer-causing virus are safe and accurate.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.